The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential role of residual metabolic tumor volume in patients with inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
 
Marcus Unterrainer
No Relationships to Disclose
 
Julian Taugner
No Relationships to Disclose
 
Lukas Käsmann
No Relationships to Disclose
 
Chukwuka Eze
No Relationships to Disclose
 
Wolfgang G. Kunz
No Relationships to Disclose
 
Amanda Tufman
No Relationships to Disclose
 
Niels Reinmuth
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
 
Claus Belka
No Relationships to Disclose
 
Farkhad Manapov
No Relationships to Disclose